Abstract
During two pivotal clinical trials of the infliximab biosimilar CT-P13 (PLANETAS and PLANETRA), antidrug antibodies (ADAs) and neutralising antibodies (NAbs) were detected in the sera of patients treated with CT-P13 and the reference product (RP; Remicade). The aim was to assess the comparability of Remicade- and CT-P13-tagged immunoassays for the detection of ADAs and NAbs using data from these trials, in order to determine the cross-reactivity of CT-P13 and RP ADAs. Sera from patients with rheumatoid arthritis and ankylosing spondylitis were analysed using an electrochemiluminescence (ECL) bridging assay or Gyros immunoassay, tagged with Remicade or CT-P13 at screening, weeks 14, 30 and 54, and the end of study visit. NAb titre was compared at screening and weeks 14 and 30. The proportion of cross-reactive samples was determined and an inter-rater agreement analysis performed to assess the concordance of results between assays. In PLANETAS, 93.1% (94/101) of RP ADA-positive samples and 93.0% (93/100) of RP NAb-positive samples cross-reacted with CT-P13; 99.0% (103/104) of CT-P13 ADA-positive and 98.0% (98/100) of CT-P13 NAb-positive samples cross-reacted with the RP. In PLANETRA, 94.7% (426/450) of RP ADA-positive samples and...Continue Reading
References
Aug 1, 1989·Scandinavian Journal of Immunology·A FomsgaardK Bendtzen
Mar 1, 1988·Arthritis and Rheumatism·F C ArnettH S Luthra
Apr 1, 1984·Arthritis and Rheumatism·S van der LindenA Cats
May 2, 2007·FEBS Letters·Masato WatanabeKoh Nakata
Nov 11, 2008·Journal of Pharmaceutical and Biomedical Analysis·Gopi ShankarEugen Koren
Mar 17, 2011·The American Journal of Gastroenterology·Alexander C FordPaul Moayyedi
Jan 25, 2012·PloS One·Kalle J AaltonenMarja Blom
Dec 1, 2012·Immunotherapy·Klaus Bendtzen
Dec 12, 2012·Annals of the Rheumatic Diseases·Sandra GarcêsElizabeth Benito-Garcia
May 21, 2013·Annals of the Rheumatic Diseases·Won ParkJürgen Braun
May 21, 2013·Annals of the Rheumatic Diseases·Dae Hyun YooUlf Müller-Ladner
Jun 26, 2013·JAMA Internal Medicine·Jose Ramon ManeiroJuan Jesus Gomez-Reino
Apr 15, 2014·Rheumatology International·Lívia Lovato Pires LemosFrancisco Assis Acurcio
Oct 25, 2014·Annals of the Rheumatic Diseases·K A van SchieT Rispens
Apr 22, 2015·Gut·Shomron Ben-HorinYehuda Chowers
Aug 19, 2015·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sarah S ThomasDaniel E Furst
Sep 24, 2015·Expert Review of Clinical Immunology·Ji Soo KimSeungSuh Hong
Jan 23, 2016·Arthritis Research & Therapy·Won ParkJürgen Braun
Feb 6, 2016·Health Technology Assessment : HTA·Mark CorbettStephen Palmer
Mar 10, 2016·Inflammatory Bowel Diseases·Ann GilsPaul J Declerck
Mar 12, 2016·Annals of the Rheumatic Diseases·M Begoña Ruiz-ArgüelloDaniel Nagore
Apr 4, 2016·Arthritis Research & Therapy·Dae Hyun YooWon Park
Apr 22, 2016·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Carlos PinedaClaudio Carini
Apr 28, 2016·Annals of the Rheumatic Diseases·Won ParkJürgen Braun
May 1, 2016·Annals of the Rheumatic Diseases·Dae Hyun YooWon Park
Sep 15, 2016·Annals of the Rheumatic Diseases·Dae Hyun YooWon Park
Citations
Nov 28, 2017·Journal of Comparative Effectiveness Research·Dae Hyun Yoo
Jun 20, 2018·Expert Review of Clinical Immunology·Dae Hyun YooChang-Hee Suh
Sep 1, 2018·Journal of Pediatric Gastroenterology and Nutrition·Lissy de RidderUNKNOWN Paediatric IBD Porto group of ESPGHAN
Mar 2, 2018·Current Treatment Options in Gastroenterology·Frank I Scott, Gary R Lichtenstein
Apr 25, 2019·Current Gastroenterology Reports·Thomas X Lu, Russell D Cohen
Sep 19, 2017·Bioanalysis·Janka RydingMartin Ullmann
Dec 7, 2019·Expert Opinion on Drug Discovery·Ido Veisman, Shomron Ben-Horin
Apr 3, 2020·Clinical Pharmacology and Therapeutics·Liese BarbierIsabelle Huys
Jun 11, 2020·Immunotherapy·Seung Wook HongByong Duk Ye
Aug 18, 2020·Expert Opinion on Biological Therapy·Tommaso Lorenzo ParigiSilvio Danese
Feb 21, 2018·Inflammatory Bowel Diseases·Gionata FiorinoSilvio Danese
Feb 21, 2018·Inflammatory Bowel Diseases·Konstantinos H KatsanosDimitrios K Christodoulou
Dec 1, 2018·Future Oncology·Hope S RugoGeraint Morgan
Sep 6, 2019·British Journal of Clinical Pharmacology·Fernando de MoraRafael Martínez
Nov 14, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Vibeke StrandJohn D Isaacs
Jan 18, 2020·Rheumatology and Therapy·Roy FleischmannPaul Declerck
Oct 28, 2019·Annals of Laboratory Medicine·Maurizio BenucciRoberto Verna
Sep 10, 2020·Journal of Clinical Pharmacology·Alexander EserDiane R Mould
May 6, 2019·Reumatología clinica·Miguel Ángel Abad HernándezJuan J Gómez-Reino
Mar 22, 2021·Advances in Therapy·Anita AfzaliPhilip J Molloy
May 11, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Md Golam KibriaYutaka Kuroda
Oct 14, 2021·PloS One·Kazuto NakaeKazuo Matsubara